Sulfonylurea drugs do not influence initial stroke severity and in-hospital outcome in stroke patients with diabetes

Stroke

Volumn 32, Issue 9, 2001, Pages 2029-2032

  Weih, Markus ^a   Amberger, Nicola ^a   Wegener, Susanne ^a   Dirnagl, Ulrich ^a   Reuter, Thomas ^a   Einhäupl, Karl ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

Author keywords

Cerebral ischemia; Clinical study; Hypoxia; Preconditioning

Indexed keywords

ACARBOSE; GLIBENCLAMIDE; INSULIN; METFORMIN; PLACEBO; SULFONYLUREA DERIVATIVE;

ADULT; AGED; ARTICLE; BRAIN ISCHEMIA; DIABETES MELLITUS; DISEASE SEVERITY; DRUG EFFECT; FEMALE; GLUCOSE BLOOD LEVEL; HOSPITAL ADMISSION; HUMAN; HYPERGLYCEMIA; HYPOXIA; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PRIORITY JOURNAL; RATING SCALE; SECRETORY GRANULE; STROKE;

EID: 0034825944     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/str.32.9.2029     Document Type: Article

References (31)

1. Stroke in the diabetic patient
2. Diabetes and cardiovascular disease: The Framingham Study
3. The effect of intensive treatment of diabetes on the development and progression of complications in diabetes mellitus
4. Increased damage after ischemic stroke in patients with hyperglycemia with or without established diabetes mellitus
5. Mortality from coronary heart disease and stroke in relation to degree of glycaemia: The Whitehall Study
6. Stroke topography and outcome in relation to hyperglycaemia and diabetes
7. Overview of bioenergetic failure and metabolic cascades in brain ischemia
8. Sulfonylurea drugs increase early mortality in patients with diabetes mellitus after direct angioplasty for acute myocardial infarction
9. Prevalence and mortality of acute myocardial infarction in patients with diabetes
10. A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes
11. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes
12. Relation between sulfonylurea therapy, complications, and outcome for elderly patients with acute myocardial infarction
13. Myocardial infarction in diabetic vs non-diabetic subjects: Survival and infarct size following therapy with sulfonylureas
14. Ischemic preconditioning during coronary angioplasty is prevented by glibenclamide, a selective ATP-sensitive K+ channel blocker
15. Rapid preconditioning neuroprotection following anoxia in hippocampal slices: Role of the K+ ATP channel and protein kinase C
16. Essential role of adenosine, adenosine A1 receptors, and ATP-sensitive K+ channels in cerebral ischemic preconditioning
17. Sulfonylurea binding sites in normal human brain and in Parkinson's disease, progressive supranuclear palsy and Huntington's disease
18. Modulation of K+ channels by intracellular ATP in human neocortical neurons
19. Treatment of ischaemic stroke
20. Classification of subtype of acute ischemic stroke: Definitions for use in a multicenter clinical trial: TOAST: Trial of Org 10172 in Acute Stroke Treatment
21. Retrospective assessment of initial stroke severity with the Canadian Neurological Scale
22. 1999 WHO-International Society of Hypertension Guidelines for the management of hypertension
23. Inter-observer agreement for the assessment of handicap in stroke patients
24. The Canadian Neurological Scale: Validation and reliability assessment
25. Attenuated stroke severity after prodromal T1A: Is it ischemic tolerance?
26. A study of the effects of hypoglycemia agents on vascular complications in patients with adult-onset diabetes, VI: Supplementary report on nonfatal events in patients treated with tolbutamide
27. Do transient ischemic attacks have a neuroprotective effect?
28. Molecular characterization of human SUR2-containing K(ATP) channels
29. Interaction of sulphonylurea derivatives with vascular ATP-sensitive potassium channels in humans
30. Hypercapnia-induced cerebral and ocular vasodilation is not altered by glibenclamide in humans
31. Diabetes, coronary heart disease and sulphonylureas: Not the final word